Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease

NCT01856738 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

91

Enrollment

OTHER

Sponsor class

Stopped enrollment to slow, insufficient funds

Conditions

Parkinson's Disease

Interventions

DRUG: Rivastigmine
DRUG: Placebo (for rivastigmine)

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]